July 24, 2019

Dr. Steve Wrenn (left) in his laboratory with PhD candidate Michael Cimorelli (middle) and BS/MS Mike Flynn (right). Photo by Amy Campbell

In a groundbreaking invention that could change how chest pain is diagnosed and treated, researchers at Drexel’s College of Engineering and Drexel’s College of Medicine have developed a novel voltage-activated contrast agent that detects heart disease by “lighting up” healthy tissue, while leaving damaged or blocked tissue dark. Called Electrast, the agent responds to the heart’s own electrical activity to become visible with ultrasound when in the presence of the myocardium, providing instant, low-cost, bedside feedback on how efficiently blood is being pumped through the heart.

Read full article on EXEL Magazine